Evaluation of serum amyloid A as a biomarker for sepsis diagnosis compared with C-reactive protein, procalcitonin, and presepsin

Key Points

• This research aims to evaluate the effectiveness of serum amyloid A in diagnosing sepsis compared to traditional biomarkers.
• Analyzed serum amyloid A, C-reactive protein, procalcitonin, and presepsin levels.
• Compared diagnostic accuracy using clinical samples.
• Assessed the potential of a combinatory approach.
• Serum amyloid A showed promising diagnostic potential for sepsis.
• Using SAA alongside CRP, PCT, and presepsin improved the overall diagnostic accuracy.